David Altshuler

David Altshuler
Name	David Altshuler
Birth date	01 January 1940
Birth place	Boston, Massachusetts, United States
Nationality	American
Occupation	Geneticist; Investigator; Author
Alma mater	Harvard University; Massachusetts Institute of Technology
Known for	Human genetics; population genetics; disease gene mapping

David Altshuler

David Altshuler is an American physician-scientist and geneticist known for leadership in human genetics, genomic medicine, and translational research. He has held senior roles at academic institutions and biotechnology organizations, contributing to efforts that bridge basic genetics with clinical applications. Altshuler's work intersects with large-scale initiatives, collaborative consortia, and policy-shaping groups in genomics.

Early life and education

Altshuler was born in Boston and raised in the greater Boston area, where formative influences included regional biomedical centers such as Massachusetts General Hospital and academic environments like Harvard Medical School. He completed undergraduate studies at Harvard University and pursued medical training at Harvard Medical School, followed by doctoral and postdoctoral work at the Massachusetts Institute of Technology and affiliated laboratories. His mentors and collaborators during training connected him with figures from institutions such as Cold Spring Harbor Laboratory, National Institutes of Health, Broad Institute, and clinical centers including Brigham and Women's Hospital.

Career and professional work

Altshuler's career spans roles in academia, non-profit research, and industry. He served on faculty at Massachusetts General Hospital and held leadership posts at the Broad Institute and other centers that coordinate genomic research across institutions such as Harvard University, MIT, Stanford University, and University of California, San Francisco. He participated in national and international consortia including the Human Genome Project, the International HapMap Project, and initiatives allied with the National Human Genome Research Institute and the Wellcome Trust. In industry and translational domains, Altshuler engaged with biotechnology firms and academic-industry partnerships similar to those linking Genentech, Merck, Pfizer, and translational networks associated with Broad Institute spinouts. He has advised governmental and philanthropic funders, interacting with organizations such as the National Institutes of Health, the Bill & Melinda Gates Foundation, and the Howard Hughes Medical Institute.

Research and contributions

Altshuler's research focuses on human population genetics, complex trait mapping, genotype-phenotype associations, and the implementation of genomic data in clinical contexts. He made contributions to haplotype mapping and linkage disequilibrium frameworks utilized by projects like the International HapMap Project and follow-on efforts such as the 1000 Genomes Project. His group developed analytical methods and resources that informed genome-wide association studies implemented across diseases studied by consortia including the Wellcome Trust Case Control Consortium and disease-focused networks at institutions like Johns Hopkins University, Stanford University, Columbia University, and University of Oxford.

Altshuler's translational work examined pharmacogenomics and the genetic architecture of metabolic traits, collaborating with investigators from centers such as Brigham and Women's Hospital, Massachusetts General Hospital, Yale University, and University of Cambridge. He participated in population sequencing efforts that sampled diverse cohorts, contributing knowledge relevant to population studies involving Iceland-based efforts at deCODE genetics, island population analyses at Sardinia research initiatives, and multi-ethnic studies conducted with teams at University of California, Los Angeles and University of Chicago.

He has been active in genomic medicine policy debates and practical implementation, interacting with stakeholders from regulatory bodies and professional societies including the Food and Drug Administration, the American College of Medical Genetics and Genomics, and advisory groups that consult with the National Institutes of Health and the Centers for Disease Control and Prevention.

Publications and writings

Altshuler is author or co-author on numerous peer-reviewed articles in journals such as Nature, Science, The New England Journal of Medicine, Cell, and Nature Genetics. His publications report findings from genome-wide association studies, methodological papers on haplotype phasing and imputation, and translational studies linking genetic variation to clinical phenotypes and drug response. He has contributed chapters and reviews in volumes associated with institutions like Cold Spring Harbor Laboratory Press and editorial roles for journals operated by publishers such as Nature Publishing Group and Elsevier. Altshuler has presented keynote lectures at meetings organized by societies including the American Society of Human Genetics, the European Society of Human Genetics, and conferences hosted by the Genome Institute networks.

Awards and recognition

Altshuler's work has been recognized by awards and honors from academic and professional organizations. He has received grant support and prizes associated with funding agencies such as the National Institutes of Health and foundations like the Wellcome Trust and Howard Hughes Medical Institute. Institutional honors include appointments and visiting professorships at universities including Harvard University, Massachusetts Institute of Technology, and invited fellowships related to collaborative centers such as the Broad Institute and international research consortia. His contributions to genetics and genomic medicine have been cited in policy reports and white papers from advisory bodies including the National Academies of Sciences, Engineering, and Medicine and international health organizations.

Category:American geneticists Category:Physician-scientists Category:Harvard Medical School faculty